Translational Session
Future Shock: Transformational Therapies for Kidney Failure
November 03, 2022 | 02:00 PM - 04:00 PM
Location: WF3 Tangerine, Orange County Convention Center, West Building
Session Description
Kidney failure remains a global health problem, and current therapeutic options are associated with ongoing morbidity and mortality risks. In recent years, efforts from stakeholders such as KidneyX and the Kidney Health Initiative have incentivized transformative therapeutic innovation. Patients are also advocating for fundamentally new treatment choices. This session describes the current efforts to develop transformational therapies for treating kidney failure.
Support is provided by an educational grant from eGenesis, Inc.
Learning Objective(s)
- Describe the current landscape, clinical rationale, and technical barriers for the development of portable and wearable forms of hemodialysis
- Describe the current landscape, clinical rationale, and technical barriers for the development of implantable forms of RRT
- Report updated knowledge about human genome editing and how it may apply to genetic causes of kidney diseases
- Discuss patient perspectives on the potential for patient-centered device design and for evaluating risk-benefit ratios for innovative kidney failure therapeutics
Learning Pathway(s)
- Kidney Transplantation
Moderators
- Raymond C. Harris, MD, FASN
- Melissa West
Presentations
- Where Are We with Portable and Wearable Hemodialysis?
02:00 PM - 02:30 PM
Jonathan Himmelfarb, MD, FASN
- Progress Toward Implantable Artificial Kidneys
02:30 PM - 03:00 PM
Shuvo Roy, PhD
- Cure Is the Best Treatment: Genome Editing
03:00 PM - 03:30 PM
Jeremy Stuart Duffield, MD, MBChB, PhD
- Making Sure the Patient Perspective Is Heard: The Kidney Health Initiative Patient and Family Partnership Council
03:30 PM - 04:00 PM
Leigh-Ann Williams, MS, MPH
